RESEARCH ARTICLE

Effect of fermented sarco oyster extract on age induced sarcopenia muscle repair by modulating regulatory T cells

Kyung-A Byun1https://orcid.org/0000-0001-7486-9137, Seyeon Oh2https://orcid.org/0000-0002-3565-7139, Sosorburam Batsukh1,2https://orcid.org/0009-0004-8753-3244, Kyoung-Min Rheu3https://orcid.org/0000-0002-4250-6179, Bae-Jin Lee3https://orcid.org/0009-0004-5257-0176, Kuk Hui Son4,*https://orcid.org/0000-0002-0595-5645, Kyunghee Byun1,2,*https://orcid.org/0000-0001-8678-8932
Author Information & Copyright
1Department of Anatomy & Cell Biology, College of Medicine, Gachon University, Incheon 21936, Korea
2Functional Cellular Networks Laboratory, Graduate School and Lee Gil Ya Cancer and Diabetes Institute, College of Medicine, Gachon University, Incheon 21999, Korea
3Marine Bioprocess Co., Ltd., Marine Bio-Industry Development Center, Busan 46048, Korea
4Department of Thoracic and Cardiovascular Surgery, Gil Medical Center, Gachon University, Incheon 21565, Korea
*Corresponding author: Kuk Hui Son, Department of Thoracic and Cardiovascular Surgery, Gil Medical Center, Gachon University, Incheon 21565, Korea, Tel: +82-32-460-3666, E-mail:dr632@gilhospital.com
*Corresponding author: Kyunghee Byun, Department of Anatomy & Cell Biology, College of Medicine, Gachon University, Incheon 21936, Korea, Tel: +82-32-899-6511, E-mail:khbyun1@gachon.ac.kr

Copyright © 2023 The Korean Society of Fisheries and Aquatic Science. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Mar 25, 2023; Revised: Apr 14, 2023; Accepted: Apr 14, 2023

Published Online: Jun 30, 2023

Abstract

Sarcopenia is an age-related, progressive skeletal muscle disorder involving the loss of muscle mass and strength. Previous studies have shown that γ-aminobutyric acid (GABA) from fermented oysters aids in regulatory T cells (Tregs) cell expansion and function by enhancing autophagy, and concomitantly mediate muscle regeneration by modulating muscle inflammation and satellite cell function. The fermentation process of oysters not only increases the GABA content but also enhances the content of branched amino acids and free amino acids that aid the level of protein absorption and muscle strength, mass, and repair. In this study, the effect of GABA-enriched fermented sarco oyster extract (FSO) on reduced muscle mass and functions via Treg modulation and enhanced autophagy in aged mice was investigated. Results showed that FSO enhanced the expression of autophagy markers (autophagy-related gene 5 [ATG5] and GABA receptor-associated protein [GABARAP]), forkhead box protein 3 (FoxP3) expression, and levels of anti-inflammatory cytokines (interleukin [IL]-10 and transforming growth factor [TGF]-β) secreted by Tregs while reducing pro-inflammatory cytokine levels (IL-17A and interferon [IFN]-γ). Furthermore, FSO increased the expression of IL-33 and its receptor IL-1 receptor-like 1 (ST2); well-known signaling pathways that increase amphiregulin (Areg) secretion and expression of myogenesis markers (myogenic factor 5, myoblast determination protein 1, and myogenin). Muscle mass and function were also enhanced via FSO. Overall, the current study suggests that FSO increased autophagy, which enhanced Treg accumulation and function, decreased muscle inflammation, and increased satellite cell function for muscle regeneration and therefore could decrease the loss of muscle mass and function with aging.

Keywords: Fermented sarco oyster extract; Gamma-aminobutyric acid; Lactic acid; Regulatory T cell; Sarcopenia

Introduction

Sarcopenia, characterized by a decline in muscle mass and function, is known to increase with age (Dodds et al., 2014). Currently, more than 10% of elderly individuals reportedly experience sarcopenia (Ethgen et al., 2017). In Europe, the prevalence of sarcopenia is expected to increase by approximately 72.4% between 65 and 100 years of age by 2045 (Ethgen et al., 2017). Although the mechanism underlying the pathogenesis of sarcopenia needs to be comprehensively elucidated, abnormalities in immune regulation or chronic inflammation are considered to be the main pathophysiology of sarcopenia (Afzali et al., 2018). The regenerative ability of skeletal muscles, muscle function, and muscle mass reportedly decrease during the aging process (Jang et al., 2011). Skeletal muscle consists of post-mitotic and multinucleated cells; thus, these cells typically remain in a quiescent state. However, muscle injuries induce a robust regeneration response, and satellite cells that are committed and self-renewable precursors undergo activation, proliferation, and differentiation (Jang et al., 2011). With aging, satellite cell numbers and functions decrease, associating with declining muscle generation ability (Jang et al., 2011).

Various immune cells play a role in muscle regeneration. Cluster of differentiation (CD) 4+forkhead box P3 (FoxP3)+ regulatory T cells (Tregs) are the dominant T cell subset infiltrating skeletal muscles. Notably, CD4+FoxP3+ Tregs account for 50% of CD+ T cells in the muscle and control inflammation during muscle repair (Burzyn et al., 2013). During muscle repair, the interleukin (IL)-33 signaling pathway is involved in Treg function. IL-33 binds to its receptor ST2 (also known as IL-1 receptor-like 1) and increases Treg proliferation (Kuswanto et al., 2016). IL-33 is primarily secreted by epithelial cells; however, M2 macrophages may also secrete IL-33 (Furukawa et al., 2017).

Tregs play a role in macrophage M2 polarization and increase IL-10 secretion during muscle repair (Burzyn et al., 2013; Deng et al., 2012). Both M1 and M2 macrophages mediate essential functions during muscle repair. Immediately after muscle injury, M1 macrophages, known to exhibit pro-inflammatory characteristics, appear and trigger satellite cell proliferation (Arnold et al., 2007). Subsequently, M1 macrophages shift to M2 macrophages for mediating muscle regeneration. M2 macrophages exhibit anti-inflammatory characteristics and enhance myoblast fusion and myotube hypertrophy (Arnold et al., 2007).

IL-10 is essential for skeletal muscle repair (Deng et al., 2012). Tregs in skeletal muscle can secrete both IL-10 and the epidermal growth factor-like ligand amphiregulin (Areg), especially after sterile muscle injury (Burzyn et al., 2013). Co-culture with Tregs enhances satellite cell proliferation (Castiglioni et al., 2015) Areg, which is secreted by muscle Tregs, directly acts on satellite cells and triggers muscle regeneration (Burzyn et al., 2013). The essential role of Areg-producing Tregs for muscle regeneration was demonstrated in an animal model with specific ablation of Treg cells (Arpaia et al., 2015).

Collectively, Tregs can play various roles in regulating muscle inflammation and satellite cell function during muscle regeneration. Aging decreases Treg-mediated immunological regulation during muscle regeneration (Domingues-Faria et al., 2016). Furthermore, Treg infiltration in aged muscles is reduced due to various factors related to Treg population dynamics, including Treg recruitment, proliferation, and retention (Kuswanto et al., 2016). Autophagy is a crucial regulator of Treg stability and survival (Wei et al., 2016). Autophagy-related (ATG) proteins play an essential role during autophagy as the ‘core machinery’ of autophagy (Yang et al., 2010). Mice with specific deletion of ATG5 in Treg cells (Foxp3CreAtg5fl/fl) reportedly demonstrate disordered homeostasis in CD4+ and CD8+ cells. The percentage of Tregs decreased while interferon (IFN)-γ expression increased (Wei et al., 2016).

The Crassostrea gigas oyster is a widely cultivated, industrially important shellfish in Asia because of its low impact on the natural environment and high sustainability. Furthermore, oyster meat is a great source of vitamins and essential minerals (such as zinc, iron, calcium, and selenium), and, especially glutamic acid, a precursor of γ-aminobutyric acid (GABA) (Bang et al., 2020). GABA is a well-known inhibitory neurotransmitter of the central nervous system that can act as an immunomodulatory molecule has known to affect several functions in the body, including muscle health.

The fermentation process has been known to change the biochemical component of the substance including change in the structure of amino acid (AA), and, hence altering its biological activities (Molagoda et al., 2022). AAs play an important biological and chemical role in the body, especially in building and repairing tissues. Especially, a special class of AAs known as branched-chain amino acids (BCAAs; leucine, isoleucine, and valine) has been used as a substrate for protein synthesis and can stimulate skeletal muscle synthesis and suppress proteolysis (Mann et al., 2021). Delay of AAs absorption, anabolic resistance, and low level of BCAAs are common in the elderly and are associated with the declination of muscle mass, strength, and function (Ko et al., 2020). Studies reported that supplementary BCAAs and essential AAs can attenuate sarcopenia in the elderly and stimulate muscle protein synthesis (ter Borg et al., 2019).

Our previous studies reported that that fermentation of oysters by Lactobacillus brevis BJ20 increased the amount of GABA, and lactic acid, and had a positive effect on bone formation (Molagoda et al., 2022), height growth (Jeong et al., 2021) and muscle endurance (Reid et al., 2020). Recently, we demonstrated that GABA–enriched fermented sarco oyster extract (FSO) reduced muscle proteolysis by increasing mRNA levels of insulin-like growth factor (IGF)-1 in dexamethasone-induced animals (Oh et al., 2021). Furthermore, GABA, as an immunomodulatory molecule can decrease pro-inflammatory cytokine production (Mazzoli & Pessione, 2016). Autophagy mediates immune regulation through GABA regulation. During autophagy, GABA upregulates ATG5 in the mesenchymal lymph node cells (MLNCs), decreasing the production of IFN-γ and IL-17 by MLNCs (Bajić et al., 2020), and also upregulates the expression of Foxp3+, IL-10, and transforming growth factor-β (TGF-β) in MLNCs (Bajić et al., 2020). Respectively, T helper (Th) 17 and Th1 cells secrete IL-17 and IFN-γ induces pro-inflammatory responses (Kuwabara et al., 2017) and by secreting anti-inflammatory cytokines such as IL-10 and TGF-β (Dominguez-Villar & Hafler, 2018), Tregs reduces the inflammatory response.

Although studies have shown that FSO (with high GABA and lactate content) can enhance muscle health and attenuated muscle atrophy (Oh et al., 2021), the modulation process of GABA in FSO in relation to increase in Treg in aged muscle is still unknown. The aim of this study is to determine (1) the impact of fermentation process in FSO in relation to biochemical components, especially protein-related BCAAs, and, (2) the impact of FSO on autophagy and Tregs and its modulating ability in satellite cells regeneration. Here, we used aged mice to compare the effect of FSO on muscle young mice and aged mice treated with GABA+Lactic acid administration. We hypothesized that the fermentation process results in an increase in BCAAs and lower molecular weight AA for easy absorption and FSO enhances autophagy and Tregs, which decreases IL-17 and IFN-γ and increase IL-10 and TGF-β. Furthermore, increased Tregs can also lead to elevated IL-33 levels, eventually enhancing M2 polarization.

Materials and Methods

Preparation and extraction of fermented sarco oyster extract (FSO)

In this study, the FSO used was sourced from Marine Bioprocess (Busan, Korea) and prepared as follows. Frozen and peeled oysters purchased from Deokyeon Seafood (Tongyeong, Korea) were washed, drained, and homogenized. The homogenized oysters were hydrolyzed with alcalase (Alcalase® 2.4 L, FG, Brenntag Korea, Seoul, Korea) at 60 ± 5°C for 4 hours, then filtered with a vibrating sieve (120 mesh, Buchi Labortechnik GmbH, Essen, Germany), and concentrated using a rotary evaporator (Buchi Labortechnik GmbH).

To manufacture the FSO, L. brevis BJ20 (accession no. KCTC 11377BP) and Lactobacillus plantarum BJ21 (accession no. KCTC18911P) were separately inoculated into sterilized (121°C, 15 min) seed medium (yeast extract 3%, glucose 1%, monosodium glutamate 1%, water 95%) and cultured at 37°C for 24 hours. Next, 10% (v/v) of the L. brevis BJ20 cultured seed medium was fermented in a fermentation medium (yeast extract 2%, glucose 2%, L-glutamic acid 5%, hydrolyzed oyster extract 50%, water 41%) at 37°C for 24 hours. After that, 10% (v/v) of the L. plantarum BJ21 cultured seed medium was added to the previous medium and fermented at 37°C for 24 hours. The fermentation medium was filtered (disk separator, Alfa Laval, CLARA 200), concentrated, and spray-dried to prepare powder sample FSO, which contained GABA (11.2%), lactic acid (5.0%), water (5.5%), protein (31.8%), and carbohydrate (56.1%) (Oh et al., 2021).

Chemical and reagent

GABA, L-(+)-lactic acid, and sodium acetate (50 mM, pH 6.5) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile, Methanol, and distilled water were high-performance liquid chromatography (HPLC)-grade and were purchased from Samchun Pure Chemical (Pyeongtaek, Korea). The hydrochloric acid solution was purchased from Biosesang (Seongnam, Korea). OPA regent (10 mg/mL, Agilent P/N 5061-3335) and borate buffer (0.4 N in water, pH 10.2; Agilent P/N 5061-3339) were purchased from Agilent Technologies (Palo Alto, CA, USA). Acetic acid, monopotassium phosphate, and phosphoric acid were purchased from Junsei Chemical (Tokyo, Japan).

Standard solution and sample preparation

L-(+)-lactic acid and GABA stock solution were prepared by dissolving 0.1 g of each chemical with 100 mL of distilled water in a volumetric flask. Solutions were filtered through PTFE Syringe Filter (Lbscience, Busan, Korea), 25 mm/0.2 μm to remove small particles. The solutions were kept at –80°C. For the 5% aqueous sample solution, 5 g of FSO was dissolved in a 100 mL volumetric flask with distilled water. For lactic acid analysis, the sample solution was diluted 20X with distilled water and for GABA analysis, the sample solution was diluted 20X with 0.02 M HCl aqueous solution. Each solution was filtered through PTFE Syringe Filter, 25 mm/0.2 μm.

γ-Aminobutyric acid (GABA) high-performance liquid chromatography (HPLC) analysis

GABA content was determined using a HPLC system (Dionex U3000; Thermo Fisher Scientific, Sunnyvale, CA, USA) equipped with a UV detector. Dionex bonded silica column (C18, 5 μm 120 Å 4.6 × 50 mm) fitted with 4.0 × 3.0 mm i.d. guard column, both from Phenomenex (Torrance, CA, USA), were used. Solvent A was 50 mM sodium acetate (pH 6.5), and solvent B consisted of 45% (v/v) acetonitrile, 45% (v/v) methanol, and 10% (v/v) distilled water. The linear gradient was conducted for 30 min at 338 nm with an injection volume of 20 µL.

Lactic acid high-performance liquid chromatography (HPLC) analysis

Lactic acid content was determined using a HPLC system (Dionex U3000) equipped with a UV detector. Dionex bonded silica column (C18 5μm 120 Å 4.6 × 250 mm) fitted with 4.0 × 3.0 mm i.d. guard column, both from Phenomenex, were used. For isolation condition analysis, solvent A was 0.2 M potassium phosphate (pH 2.4). The isocratic was conducted for 15 min at 214 nm and the injection volume was 20 µL. The solvent flow rate was 0.8 mL/min. The colunm temperature during the analysis was kept at 40°C.

Amino acids (AAs) analysis

The AA analysis of FSO to determine and compare the content of protein-bound amino acids (PAAs) and FAAs; pre-and post-fermentation was accomplished by Pukyong National University (Busan, Korea).

In-vivo study mice model

We obtained male and female C57BL/6N mice, aged six weeks, from Orient Bio (Seoul, Korea). After the adaptation period, the males and females were paired for mating, and their offspring were observed for either 4 or 12 months. The male mice that were raised for 4 months were categorized as the young group (n = 5), while the 12-month-old males were randomly assigned to five aging groups (n = 5 per group). In total, the mice were divided into six groups.

  • 1) Young/Saline: Saline was orally administered to 4-month-old animals.

  • 2) Aging/Saline: Saline was orally administered to 12-month-old animals.

  • 3) Aging/FSO50: FSO 50 mg/kg/day was orally administered to 12-month-old animals.

  • 4) Aging/FSO100: FSO 100 mg/kg/day was orally administered to 12-month-old animals.

  • 5) Aging/FSO200: FSO 200 mg/kg/day was orally administered to 12-month-old animals.

  • 6) Aging/GABA+Lactic acid: GABA at 5 mg/kg/day and lactic acid at 4 mg/kg/day were orally administered to 12-month-old animals.

Oral administration was performed for four weeks, and a grip strength test was subsequently performed. All animal experiments were approved and performed according to the ethical principles of the Institutional Animal Care and Use Committee of Gachon University (approval no. LCDI-2021-0074).

In-vivo grip strength test

Following a 4-week period of oral administration, we assessed the grip strength of mice using a grip strength meter (Jeungdo Bio & Plant, Seoul, Korea). The grip strength meter provides a digital readout of the maximum force. To measure the grip strength, the mouse was placed on the meter bar, and its tail was gently pulled. We performed ten measurements at 30 s intervals and calculated the average grip strength.

In-vivo sample preparation-paraffin-embedded tissues

We collected muscles from mice and preserved them by immersing them in 4% paraformaldehyde (Sigma-Aldrich) dissolved in cold phosphate-buffered saline (PBS; Biosesang) for 24 h at 4°C. The fixed muscles were washed with tap water for 1 h and then processed for dehydration and wax infiltration using a tissue processor (Sakura Finetek, Tokyo, Japan). Finally, the tissues were embedded in the direction of the cross-sectional area (CSA) using an embedding machine (Sakura Finetek).

In-vivo sample preparation-protein isolation

To extract proteins from frozen muscles, we lysed 50 mg of muscle tissue with 0.5 mL of radioimmunoprecipitation assay lysis buffer containing protease and phosphatase inhibitors (ATTO, Tokyo, Japan). The tissue was then homogenized using a bead homogenizer (Allsheng Instrument, Hangzhou, China) at 6.0 m/s for 10 cycles (running for 40 s and interrupting for 60 s). After sonication, the homogenized tissue was centrifuged at 14,000×g for 20 min at 4°C. The supernatant was transferred to a new tube and quantified using a bicinchoninic acid assay kit (Thermo Fisher Scientific).

In-vivo sample preparation-RNA extraction & complementary DNA (cDNA) synthesis

The total RNA was extracted following the manufacturer’s instructions. To summarize, we added 100 mg of frozen muscle to 1 mL RNAiso (Takara, Tokyo, Japan) and homogenized it at 6.0 m/s for 10 cycles (running for 40 s, interrupted for 60 s) using a bead homogenizer (Allsheng Instrument). After incubating the homogenized tissue for 5 min at room temperature and centrifuging it at 12,000×g for 5 min at 4°C, the supernatant was transferred to a new tube. Then, we added 0.2 mL of chloroform, vigorously vortexed the mixture, and incubated it for 5 min at room temperature, followed by centrifugation at 12,000×g for 15 min at 4°C. Afterward, we transferred the upper layer to a new tube, added 0.5 mL of isopropanol, incubated it for 10 min at room temperature, and centrifuged it at 12,000×g for 10 min at 4°C. We discarded the solution, added 1 mL of 75% ethanol, and centrifuged it at 7,000×g for 5 min at 4°C. Then, we discarded the solution, leaving only the RNA pellet, which was air-dried and dissolved in 50 µL diethyl pyrocarbonate-treated water.

We followed the manufacturer’s protocol to synthesize complementary DNA (cDNA) using the PrimeScript First Strand cDNA Synthesis Kit (Takara). To summarize, RNA was quantified using a Nanodrop (Thermo Scientific), and 1 µg of RNA was added to a new tube. Then, 1 µL of Oligo dT Primer, 1 µL of dNTP mixture, and RNase-free dH2O were added to bring the total volume to 10 µL. The solution was incubated for 5 min at 65°C and then cooled on ice. Next, 4 µL of 5X PrimeScript Buffer, 0.5 µL of RNase Inhibitor, 1 µL of PrimeScript RTase, and 4.5 µL of RNase-free dH2O were added to the sample to achieve a final volume of 20 µL. The mixture was then incubated for 45 min at 42°C, followed by 5 min at 95°C, and then cooled on ice.

Immunofluorescence

The paraffin-embedded muscle blocks were sliced into 7 µm thick sections and placed on silane-coated slides (Muto Pure Chemical, Tokyo, Japan) and left to dry for 24 h at 60°C in a slide warmer (JISICO, Seoul, Korea). The slides were deparaffinized and incubated with normal animal serum to prevent non-specific antibody binding. Primary antibodies (Supplementary Table S1) were applied to the tissues at 4°C overnight, and rinsed three times with PBS. Subsequently, secondary antibodies (Supplementary Table S1) were added for 1 hour at room temperature, followed by three PBS rinses. The tissues were then counterstained with 4`,6-diamidino-2-phenylindole (Sigma-Aldrich) and mounted with Vectashield mounting medium (Vector Laboratories, Burlingame, CA, USA). Stained tissue images were captured using a confocal microscope (LSM 710, Carl Zeiss, Oberkochen, Germany) at the Core Facility for Cell to In-Vivo Imaging (Incheon, Korea) and images were analyzed with the Zen 2009 software (Carl Zeiss).

Immunohistochemistry (3,3-diaminobenzidine [DAB])

The slides were deparaffinized and blocked with normal animal serum to prevent non-specific antibody binding. Tissues were incubated with primary antibodies (Supplementary Table S1) overnight at 4°C and rinsed thrice with PBS. Then, the tissues were treated with biotinylated secondary antibodies (Supplementary Table S1) for 1 h at room temperature and rinsed thrice with PBS. The tissues were then incubated with ABC reagent (Vector Laboratories) for 30 min, rinsed thrice with PBS, and reacted with 3,3-diaminobenzidine (DAB) substrate for 2 min. The tissues were finally mounted with a distyrene–plasticizer–xylene mounting solution (DPX; Sigma-Aldrich). Images of stained tissues were captured using a light microscope (Olympus, Tokyo, Japan), and the intensity of the brown color was quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA).

Hematoxylin and eosin staining

The slides were then deparaffinized and stained with hematoxylin (Dako, Glostrup, Denmark) and eosin Y (Sigma-Aldrich) for 30 s each. The stained tissues were mounted with DPX (Sigma-Aldrich). Images of stained tissues were captured using a light microscope (Olympus), and the mean fiber CSA was quantified using ImageJ software (National Institutes of Health).

Western blotting

The 30 μg of protein was isolated and separated on 8%–12% polyacrylamide gels, followed by transfer onto polyvinylidene fluoride membranes (Millipore, Burlington, MA, USA) using a power station (ATTO). Next, the membranes were blocked with 5% skim milk for 1 h and washed with Tris-Buffered Saline containing 0.1% Tween 20 (TTBS). The membranes were then incubated with primary antibodies (Supplementary Table S1) overnight at 4°C and washed three times with TTBS. Following this, peroxidase-conjugated secondary antibodies (Supplementary Table S1) were incubated with the membranes for 1 h at room temperature and washed three times with TTBS. Finally, the membranes were visualized using a western blotting detection reagent (Cytiva, Seoul, Korea).

Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)

To perform quantitative reverse transcription-polymerase chain reaction (qRT-PCR), cDNA was prepared and amplified using the CFX384 TouchTM Real-Time PCR detection system (Bio-Rad Laboratories, Hercules, CA, USA). Specifically, 200 ng of cDNA was combined with 5 µL of SYBR premix (Takara) and 0.4 µM forward and reverse primers (Supplementary Table S2), and the threshold cycle numbers were determined using CFX ManagerTM software (Bio-Rad Laboratories).

Statistical analysis

The data are reported as mean ± SD, and all statistical analyses were conducted using SPSS version 22 (IBM Corporation, Armonk, NY, USA). The Kruskal-Wallis test was utilized for comparing each group, and a post hoc Mann-Whitney U test was conducted to determine statistical significance. In this study, different letters were assigned to groups that showed significant intergroup differences: * vs. Young/Saline; # vs. Aging/Saline; $ vs. Aging/FSO100; † vs. Aging/GABA+Lactic acid.

Results

High-performance liquid chromatography (HPLC) annalsys of lactic acid and γ-aminobutyric (GABA) in fermented sarco oyster extract (FSO)

To validate the content of FSO, the HPLC chromatogram of lactic acid and GABA standard was compared to the FSO sample HPLC analysis (Fig. 1). The mean retention time for standard lactic acid and GABA were 6.56 ± 0.03 min and 12.36 ± 0.06 min. As for FSO, the retention time for lactic acid was 6.53 ± 0.04 min and for GABA was 12.27 ± 0.04 min. Both lactic acid and GABA have a suitable resolution (> 0.5 min) from other acids and AAs in FSO.

fas-26-6-406-g1
Fig. 1. FSO chemical analysis. (A–D) HPLC chromatograph of lactic acid standard (A) and GABA standard (B) lactic acid in FSO (C) GABA in FSO (D). FSO, fermented sarco oyster extract; HPLC, high-performance liquid chromatography; GABA, γ-aminobutyric acid.
Download Original Figure
Effect of fermentation period on γ-aminobutyric (GABA) and lactic acid content in fermented sarco oyster extract (FSO)

To determine the effect of the fermentation period on GABA and lactic acid content, production-time profile measurements were made at the pre-fermentation point and at 4, 8, 12, 16, 20, 24, 28, and 32 h after fermentation (Table 1). The results showed an increase in both GABA and lactic acid after 4 h of fermentation, and then plateaued after 16 h with GABA and lactic acid content of 10.21 ± 0.19 and 5.02 ± 0.10 with slight fluctuation. The maximum content was achieved after 32 h of fermentation with values of 10.48 ± 0.25 and 5.48 ± 0.11.

Table 1. Change in lactic acid and GABA contents in FSO during fermentation
Fermentation time (h) GABA (%, w/v) Lactic acid (%, w/v)
0 0.512 ± 0.155 0.45 ± 0.12
4 0.521 ± 0.178 0.60 ± 0.16
8 4.350 ± 0.201 0.97 ± 0.11
12 8.224 ± 0.314 3.24 ± 0.15
16 10.21 ± 0.19 5.02 ± 0.10
20 10.20 ± 0.21 5.22 ± 0.17
24 10.40 ± 0.16 5.15 ± 0.08
28 10.40 ± 0.17 5.32 ± 0.15
32 10.48 ± 0.25 5.48 ± 0.11

GABA, γ-aminobutyric acid; FSO, fermented sarco oyster extract.

Download Excel Table
Effect of fermentation on the composition of protein-bound amino acids (PAAs) and free amino acids (FAAs) in fermented sarco oyster extract (FSO)

The composition of PAAs and FAAs of FSO pre- and post-fermentation are summarized in Tables 2 and 3. The comparison of PAAs composition showed that with the exception of phenylalanine, the rest of PAAs composition decreased, where glutamic acid and proline had the most significant change. As for the composition of FAA, the majority of FAAs, including BCAAs (isoleucine, leucine and valine) increased. Furthermore, in FAAs GABA increased the most, while glutamic acid; the metabolic precursor of GABA decreased the most after fermentation.

Table 2. The composition of PAAs in FSO
PAAs (mg/100 g) FSO
Pre-fermentation Post- fermentation
Aspartic acid 736.79 ± 1.02 466.14 ± 0.72
Threonine1) 357.24 ± 1.25 255.05 ± 0.88
Serine 354.1 ± 2.56 266.67 ± 1.81
Glutamic acid 2,933.84 ± 2.56 876.58 ± 1.81
Glycine 392.7 ± 1.24 280.02 ± 0.87
Alanine 566.19 ± 3.21 384.41 ± 2.26
Cystine 141.55 ± 1.21 96.1 ± 0.85
Valine1),2) 262.14 ± 2.57 159 ± 1.81
Methionine1) 168.13 ± 3.25 98.33 ± 2.29
Isoleucine1),2) 346.15 ± 1.25 207.87 ± 0.88
Leucine1),2) 527.66 ± 4.24 323.01 ± 2.99
Tyrosine 317.9 ± 1.25 201.85 ± 0.88
Phenylalanine1) 428.73 ± 2.36 2,101.22 ± 1.66
Lysine1) 574.15 ± 4.21 392.22 ± 2.82
Histidine1) 148.97 ± 2.87 84.45 ± 2.02
Arginine 1,242.26 ± 6.51 714.56 ± 4.59
Proline 3,250.08 ± 8.22 955.11 ± 5.79

1) Essential amino acids.

2) Branched-chain amino acids.

PAA, protein-bound amino acid; FSO, fermented sarco oyster extract.

Download Excel Table
Table 3. The composition of FAAs in FSO
FAAs (mg/100 g) FSO
Pre-fermentation Post-fermentation
Histidine 0.00 ± 0.00 17.96 ± 0.07
3-Methylhistidine 4.42 ± 0.86 0.00 ± 0.00
a-Amino adipic acid 2.53 ± 0.56 0.00 ± 0.00
Anserine 0.00 ± 0.00 37.23 ± 0.07
Carnosine 2.36 ± 0.46 0.00 ± 0.00
Cystathionine 1.66 ± 0.12 0.00 ± 0.00
Ethanol amine 3.25 ± 0.86 3.39 ± 0.08
Phosphor ethanol amine 0.00 ± 0.00 0.00 ± 0.00
Sarcosine 3.21 ± 0.37 0.00 ± 0.00
Urea 0.00 ± 0.00 0.00 ± 0.00
Hydroxyproline 0.20 ± 0.09 0.25 ± 0.01
Hydroxylysine 1.55 ± 0.15 0.74 ± 0.06
Valine1) 3.41 ± 0.56 16.47 ± 0.35
Isoleucine1) 50.96 ± 1.66 59.87 ± 1.13
1-Methylhistidine 0.00 ± 0.00 0.00 ± 0.00
Threonine 40.54 ± 1.16 54.15 ± 0.78
a-Amino-n-butyric acid 0.00 ± 0.00 12.47 ± 0.00
Leucine1) 86.23 ± 1.38 122.65 ± 0.93
Phenylalanine 180.09 ± 5.66 217.93 ± 0.05
β-Amino isobutyric acid 42.18 ± 1.28 5.77 ± 0.86
Methionine 29.73 ± 1.16 40.97 ± 0.78
Lysine 60.98 ± 2.56 71.67 ± 1.77
Aspartic acid 59.37 ± 5.16 68.75 ± 3.61
Serine 46.60 ± 2.36 62.81 ± 1.63
Cystine 98.63 ± 5.16 79.97 ± 3.61
Tyrosine 41.21 ± 1.26 49.25 ± 0.85
Phosphoserine 18.13 ± 0.36 16.49 ± 0.21
Ornithine 28.76 ± 1.27 0.96 ± 0.11
β-Alanine 22.81 ± 0.96 8.35 ± 0.14
Alanine 91.80 ± 2.56 39.57 ± 1.77
Proline 34.06 ± 0.76 36.17 ± 0.49
Citruline 19.22 ± 0.60 221.48 ± 0.38
Glycine 54.61 ± 0.27 58.4 ± 0.15
Glutamic acid 1,536.40 ± 10.1 12.95 ± 0.53
γ-Amino-n-butyric acid 59.97 ± 2.16 1,053.72 ± 1.48
Taurine 93.17 ± 1.60 87.56 ± 1.09
Arginine 6,320.33 ± 11.1 6,183.40 ± 7.78

1) Branched-chain amino acids.

FAA, free amino acid; FSO, fermented sarco oyster extract.

Download Excel Table
Fermented sarco oyster extract (FSO) increased autophagy in Tregs in aged muscle

We first evaluated whether FSO could increase ATG signals in Tregs. Expression of FoxP3 is essential for establishing Treg cell function during differentiation, as well as for the maintenance of Tregs in the periphery (Rudensky, 2011). Accordingly, we used FoxP3 as a Treg marker. ATG, GABARAP, and Beclin1 are frequently assessed as autophagy markers (Harada et al., 2010). Moreover, the conversion of the soluble cytosolic form of microtubule-associated protein 1A/1B-light chain 3 (LC3) I into the bound LC3II form (LC3II/LC3I) is widely used as an autophagy marker (Ouyang et al., 2010).

We observed that the number of cells co-stained with ATG5 and FoxP3 was significantly lower in aged muscle than in young muscle. However, administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid significantly increased the number of ATG5 and FoxP3 stained cells in the aged muscle. In addition, no statistical difference was observed between 100 and 200 mg/kg FSO and GABA+Lactic acid groups (Fig. 2A and 2B).

fas-26-6-406-g2
Fig. 2. Regulation of autophagy in Tregs and muscles of FSO treatment. (A and C) Co-expression of Treg marker FoxP3 and autophagy marker ATG5 (A) or GABARAP (C) in muscles of young and aged animals was analyzed using immunofluorescence (scale bar = 50 µm). Arrow indicates stained portions of autophagy marker in Tregs. (B and D) The quantitative graphs were showed the counting of positive cells of ATG5 (B) and GABARAP (D) in Tregs (FoxP3) in the immunofluorescence. (E) The protein expression of Beclin1 and LC3, autophagy markers in muscle, was analyzed by western blotting. (F and G) The quantitative graphs were represented the analysis of western blot. The protein expression of Beclin1 (C) and ratio of LC3II/LC3I (D) decreases in aged muscle, which is increased by FSO treatment. Data are presented as the mean ± SD. *p < 0.05 or **p < 0.01 second bar vs. first bar. #p < 0.05 or ##p < 0.01 vs. second bar. $p < 0.05 vs. fourth bar. p < 0.05 or ††p < 0.01 vs. sixth bar (Mann-Whitney U test). ATG5, autophagy-related 5; FSO, fermented sarco oyster extract; Foxp3, forkhead box protein 3; GABA, gamma-aminobutyric acid; GABARAP, gamma-aminobutyric acid receptor-associated protein; LC3, microtubule-associated protein 1A/1B-light chain 3; Treg, regulatory T cell.
Download Original Figure

The expression of GABARAP in FoxP3 positive cells was significantly lower in aged muscles than in young muscles. However, administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid significantly increased the number of cells co-stained with GABARAP and FoxP3 in the aged muscle. No statistical difference was observed between 100 and 200 mg/kg FSO and GABA+Lactic acid groups (Fig. 2C and 2D).

The expression of Beclin1, evaluated by western blotting, was significantly lower in aged muscles than in young muscles. However, administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid significantly increased Beclin1 expression in the aged muscle. No statistical difference was observed between 100 and 200 mg/kg FSO and GABA+Lactic acid groups (Fig. 2E and 2F).

The expression ratio of LC3II/LC3I was significantly lower in aged skeletal muscles than that in young muscles. However, administration of 100 and 200 mg/kg FSO and GABA+Lactic acid significantly increased the ratio of LC3II/LC3I expression in the aged muscle. No statistical difference was observed between 100 and 200 mg/kg FSO and GABA+Lactic acid groups (Fig. 2E and 2G). Thus, these results revealed that FSO increased autophagy in both Tregs and muscles.

Fermented sarco oyster extract (FSO) increased Treg accumulation and anti-inflammatory cytokines in the aged muscle

We evaluated muscle Treg cell accumulation by determining the mRNA expression of FoxP3. The expression of FoxP3 was significantly lower in aged muscles than in young muscles. However, administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid significantly increased FoxP3 expression in aged muscle; this effect increased in a dose-dependent manner in the FSO group. No statistically significant difference was observed between the 100 and 200 mg/kg FSO and GABA+Lactic acid groups (Supplementary Fig. S1A).

Next, we evaluated whether increased Tregs led to elevated levels of anti-inflammatory cytokines (TGF-β and IL-10) and decreased levels of proinflammatory cytokines (IFN-γ and IL-17A) in the muscle.

The mRNA expression of TGF-β was significantly lower in aged muscles than in young muscles. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid increased the expression of TGF-β in the aged muscle; this effect increased in a dose-dependent manner in the FSO group. No statistically significant difference was observed between 100 and 200 mg/kg FSO and GABA+Lactic acid groups (Supplementary Fig. S1B).

The mRNA expression of IL-10 was significantly lower in aged muscles than in young muscles. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid increased IL-10 expression in the aged muscle. The effect increased in a dose-dependent manner in the FSO group. Moreover, the 200 mg/kg FSO group demonstrated a superior effect (Supplementary Fig. S1C).

The mRNA expression of IFN-γ was significantly higher in aged muscles than in young muscles. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid decreased IFN-γ expression; this effect did not significantly differ between 100 and 200 mg/kg FSO and GABA+Lactic acid groups (Supplementary Fig. S1D).

The mRNA expression of IL-17A was significantly higher in aged muscles than in young muscles. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid de-creased IL-17A expression; this effect did not significantly differ between 100 and 200 mg/kg FSO and GABA+Lactic acid groups (Supplementary Fig. S1E).

Fermented sarco oyster extract (FSO) increased the expression of interleukin (IL)-33, ST2, and Areg and promoted M2 macrophage polarization in the aged muscle

We determined whether increased Tregs enhanced Treg function for muscle regeneration. Accordingly, IL-33, ST2, and Areg expression levels were determined using immunohistochemical staining or mRNA expression.

The expression of IL-33 was significantly decreased in aged muscle when compared with that in young muscle. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid significantly increased expression, with a dose-dependent increase observed in the FSO group. Moreover, the 200 mg/kg FSO group demonstrated a superior effect (Fig. 3A and 3B).

fas-26-6-406-g3
Fig. 3. Regulation of IL-33 and macrophage polarization by FSO treatment. (A) IL-33 expression in muscles of young and aging animals was analyzed using immunohistochemistry. Arrow indicates stained portions of IL-33 positive cells (scale bar = 100 µm). (B) IL-33 protein expression in muscle decreases in aged muscle; FSO increases the expression of this protein. (C) The protein expression of CD86 and CD206, macrophage markers in muscle, was analyzed by western blotting. (D) The protein expression of CD86, an M1 marker in muscle, increases in aged muscle, which is decreased by FSO treatment. (E) The protein expression of CD206, an M2 marker in muscle, decreases in aged muscle; FSO increases this expression. Data are presented as the mean ± SD. *p < 0.05 or **p < 0.01 second bar vs. first bar. #p < 0.05 or ##p < 0.01 vs. second bar. $p < 0.05 vs. fourth bar. p < 0.05 vs. sixth bar (Mann-Whitney U test). Areg, amphiregulin; CD, cluster of differentiation; FSO, fermented sarco oyster extract; GABA, gamma-aminobutyric acid; IL, interleukin.
Download Original Figure

The expression of ST2 was significantly decreased in aged muscle when compared with young muscle. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid significantly increased ST2 expression, with a dose-dependent increase observed in the FSO group. The increasing effect of GABA+lactic acid was significantly higher than that of 50 mg/kg FSO and was significantly lower than that of 200 mg/kg FSO. No statistically significant difference was observed between the FSO 100 mg/kg and GABA+lactic acid groups (Supplementary Fig. S2A).

Areg expression was significantly decreased in aged muscle when compared with young muscle. Administration of 100 and 200 mg/kg FSO and GABA+Lactic acid significantly increased Areg expression; the increasing effects of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid did not differ significantly (Supplementary Fig. S2B).

To determine whether increased Tregs led to M2 polarization, we performed western blotting for CD86 (M1 marker) and CD206 (M2 marker).

The expression of CD86 was significantly higher in aged muscles than in young muscles. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid decreased CD86 expression. The decreasing effects of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid did not differ significantly (Fig. 3C and 3D).

The expression of CD206 was significantly lower in aged muscles than in young muscles. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid increased CD206 expression. The increasing effects of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid did not differ significantly (Fig. 3C and 3E).

Fermented sarco oyster extract (FSO) increased satellite cells and muscle regeneration marker expression in the aged muscle

To examine satellite cell accumulation in muscle, we examined the expression of PAX7, a satellite cell marker (Sambasivan et al., 2011). The expression of PAX7 was significantly lower in aged muscles than in young muscles. Administration of 100 and 200 mg/kg FSO, and GABA+Lactic acid increased PAX7 expression. Moreover, the 200 mg/kg FSO group demonstrated a superior effect (Fig. 4A and 4B).

fas-26-6-406-g4
Fig. 4. Regulation of satellite cell PAX7 and muscle regeneration marker by FSO treatment. (A) Expression of PAX7 in the muscle of the young and aging animals was analyzed by western blotting. (B) The protein expression of PAX7 in muscle decreases in aged muscle; FSO treatment increases PAX7 expression. (C–G) The mRNA expression levels of MYF5 (C), MyoD (D), myogenin (E), MuRF-1 (F), and atrogin-1 (G) in muscle were analyzed by quantitative real-time polymerase chain reaction, normalized versus Actb, and expressed relative to levels in the Young/Saline group. Expression levels of MYF5, MyoD, and myogenin decrease in aged muscle; FSO treatment increases these expression levels. However, MuRF-1 and atrogin-1 expression increase in aged muscle; FSO treatment decreases these expression levels. Data are presented as the mean ± SD. *p < 0.05 or **p < 0.01 second bar vs. first bar. #p < 0.05 or ##p < 0.01 vs. second bar. $p < 0.05 or $$p < 0.01 vs. fourth bar. p < 0.05 or ††p < 0.01 vs. sixth bar (Mann-Whitney U test). FSO, fermented sarco oyster extract; GABA, gamma-aminobutyric acid; MuRF-1, muscle RING-finger protein-1; MYF5, myogenic factor 5; MyoD, myoblast determination gene 1; PAX7, paired box 7.
Download Original Figure

We evaluated muscle expression of myogenic determination gene number 1 (MyoD), myogenin, and myogenic factor 5 (MYF5), well-known regenerative myogenesis markers (Zammit, 2017). The expression of MYF5 was significantly decreased in aged muscle when compared with that in young muscle; administration of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid increased the expression of this marker. Moreover, the 200 mg/kg FSO group demonstrated a superior effect (Fig. 4C).

MyoD expression was significantly decreased in aged muscle when compared with that in young muscle. Administration of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid increased MyoD expression. The increasing effects of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid did not differ significantly (Fig. 4D).

Compared with young muscle, myogenin expression was significantly decreased in aged muscle. Administration of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid increased myogenin expression. The increasing effects of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid did not differ significantly (Fig. 4E).

MuRF-1 and atrogin-1 are E3 ubiquitin ligases that lead to proteolysis in skeletal muscles (Bodine et al., 2001). Compared with young muscle, expression levels of MuRF-1 and atrogin-1 were significantly increased in aged muscle; administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid decreased expression levels. The effects mediated by 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid did not differ significantly (Fig. 4F and 4G).

Fermented sarco oyster extract (FSO) increased muscle mass and improved grip strength

The gastrocnemius muscle mass was evaluated using the muscle weight (normalized by body weight), the thickest diameter of the gastrocnemius muscle, and mean muscle fiber CSA.

Muscle weight, which was normalized by body weight, was significantly lower in aged muscle than in young muscle. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid increased muscle weight. The effects of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid did not differ significantly (Fig. 5A and 5B).

fas-26-6-406-g5
Fig. 5. Regulation of muscle mass and grip strength by FSO treatment. (A and B) The mean fiber CSA of muscle was analyzed by hematoxylin and eosin staining (scale bar = 100 µm). The CSA decreases in aged muscle; FSO increases this parameter. (C and D) The muscle weight and thickness decrease in aged muscle; FSO increases these parameters. (E) The grip strength decreases in aged muscle; FSO increases this parameter. (F) Summary of this study. Data are presented as the mean ± SD. **p < 0.01 second bar vs. first bar. ##p < 0.01 vs. second bar. $p < 0.05, $$p < 0.01 vs. fourth bar. p < 0.05, ††p < 0.01 vs. sixth bar (Mann-Whitney U test). ATG5, autophagy-related 5; BW, body weight; CSA, cross-sectional area; FSO, fermented sarco oyster extract; GABARAPL, gamma-aminobutyric acid receptor-associated protein; G+L, gamma-aminobutyric acid+lactic acid; IFN-γ, interferon-gamma; IL, interleukin; LC3, microtubule-associated protein 1A/1B-light chain 3; TGF-β, transforming growth factor-beta.
Download Original Figure

The thickest muscle diameter was significantly lower in aged muscle than in young muscle; administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid increased this parameter, with the 200 mg/kg FSO group demonstrating a superior effect (Fig. 5A and 5C).

The mean muscle fiber CSA was significantly lower in aged muscle than in young muscle. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid increased muscle fiber CSA. The increasing effects of 100 mg/kg and 200 mg/kg FSO and GABA+Lactic acid did not differ significantly (Fig. 5D and 5E).

Grip strength was significantly lower in aged muscles than in young muscles. Administration of 50, 100, and 200 mg/kg FSO and GABA+Lactic acid increased grip strength; the 200 mg/kg FSO group exhibited the most prominent effect (Fig. 5F).

Discussion

GABA leads to an increase in ATG5-dependent autophagy, which eventually results in Treg function modulation and decreases pro-inflammatory cytokine levels (Bhat et al., 2010). GABA increases the expression of ATG signals, such as Unc51-like kinase 1 (ULK1), Beclin1, ATG5, LC3, and GABARAP, in MLNCs (Bhat et al., 2010). Moreover, GABA can decrease the expression levels of IL-17A and IFN-γ in MLNCs, while increasing those of IL-10 and TGF-β (Bhat et al., 2010). It is well-known that Tregs play a role in muscle regeneration by modulating inflammation and satellite cell function (Burzyn et al., 2013). Thus, we evaluated whether GABA-enriched FSO enhanced Treg function by increasing autophagy.

Fermentation is a degrading process, known to contain higher nutritious value than unfermented counterparts (Cui et al., 2020). Studies have shown that fermentation can impact the content and composition of PAAs, FAAs, GABA, and lactic acid (Cui et al., 2020). First, we evaluated the effect of fermentation on PAAs and FAAs. The results showed that after fermentation, the composition of PAAs decreased while majority of FAAs increased, including BCAA’s which are water soluble and shorter, hence easier to digest and to be absorbed. Glutamic acid is a precursor of GABA and lactic acid bacteria are one of the most effective GABA producers and have been known to aid in muscle fatigue and regeneration (Cui et al., 2020). The results showed that fermentation resulted in 70 percent GABA conversion, which coincides with our pilot study where fermentation has a significant influence on the conversion glutamic acid into GABA. For further confirmation of the fermentation effect in GABA and lactic acid production, both concentrations were measured by fermentation time increments. The results showed that within 8 hours of fermentation, the concentration of lactic acid and GABA increased, and after 16 hours of fermentation the concentration reached its peak. To ensure its maximum concentration, fermentation was prolonged to a total fermentation process of 48 hours, and the maximum amount of lactic acid and GABA were confirmed in the present study. Both analytic results showed in GABA but the concentration did differ. However, the sample lot for quantitative analysis of PAA, and FAA was different from the sample for the change in PAA and FAA before and after fermentation was different. Considering that difference in value is within the validation range of 80%–120%, both measurements can be considered valid.

The accumulation of ATG5-positive FoxP3+ cells was reduced in aged muscles. In addition, GABARAP-positive FoxP3+ cell accumulation was decreased in aged muscles. FSO administration increased both ATG5- and GABARAP-positive FoxP3+ cells, suggesting that FSO upregulated autophagy signals in Tregs, associated with Treg function. Moreover, ATG signals, including Beclin1 and LC3II/LC3I, were reduced in aged muscle, and FSO administration enhanced these signals.

Tregs exhibit potent anti-inflammatory effects. Thus, decreased Treg numbers or function in aged muscles can aggravate the catabolic effect of inflammation (Saini et al., 2016). In the present study, Treg accumulation, evaluated by determining FoxP3 expression, was decreased in aged muscle, which was increased following FSO treatment. The anti-inflammatory function of Tregs was evaluated by determining the expression of anti-inflammatory cytokines in the muscle. Expression levels of anti-inflammatory cytokines, including IL-10 and TGF-β, were significantly decreased in the aged muscle; however, these levels were increased following FSO treatment. In contrast, expression levels of pro-inflammatory cytokines, such as IL-17A and IFN-γ, were elevated in aged muscle, which was reduced following FSO treatment. This finding suggests that FSO could increase Treg accumulation and function, decreasing inflammation in the muscle.

Tregs in the muscle exhibit enhanced expression of ST2, an IL-33 receptor (Burzyn et al., 2013). The binding of IL-33 to ST2 upregulates NF-kB, ERK, p38, and JNK kinases, facilitating cytokine release, cell proliferation, and Areg secretion (Kuswanto et al., 2016).

In aged muscles, the IL-33 signaling pathway is significantly downregulated by decreased IL-33 expression and a reduced number of IL-33 secreting cells (Kuswanto et al., 2016). However, IL-33 injection can attenuate the aging-induced decrease in muscle regeneration via Treg expansion (Kuswanto et al., 2016). Injection of IL-33 can increase the number of Tregs in peripheral tissues, such as adipose tissue or the intestine. Moreover, IL-33 reportedly leads to Treg expansion in muscles (Kuswanto et al., 2016). Mice with ST2 deficiency in Tregs were found to exhibit decreased Treg accumulation in the muscle when compared with wild-type mice, along with reduced muscle regeneration ability (Kuswanto et al., 2016). In the present study, expression levels of IL-33 and ST2 were reduced in aged muscles, which were enhanced by FSO treatment. Moreover, Areg expression was reduced in aged muscle, which was enhanced by FSO treatment.

Areg, a specific growth factor secreted by Tregs in the muscle, is well-known to directly affect satellite cells and promote muscle regeneration (Burzyn et al., 2013). Tregs are also involved in macrophage polarization toward M2 (Burzyn et al., 2013). M2 macrophages are directly involved in the differentiation of activated satellite cells, which generate myotubes and form myofibers for muscle regeneration post-injury (Tidball & Wehling-Henricks, 2007). In the present study, the expression of the M1 marker (CD86) was increased, while that of the M2 marker (CD206) was decreased in the aged muscle. FSO treatment decreased the expression of CD86; however, FSO increased the expression of CD206.

Adult satellite cells typically remain in a quiescent state and express PAX7 (Brack & Rando, 2012). However, satellite cells are activated by stress or injury and begin proliferating and migrating through the sarcolemma to fuse with multinucleated myofibers (Dumont et al., 2015). Following the initiation of proliferation, PAX7 expression decreases, whereas muscle-specific transcription factors MyoD and myogenin are increased (Dumont et al., 2015). Areg treatment upregulated the expression of PAX7, a myotube activation marker (Myf5), and a myotube differentiation marker (myogenin) (Jin et al., 2018). Herein, PAX7 expression in aged muscles was decreased; FSO treatment increased expression. Myogenesis markers, including Myf5, MyoD, and myogenin, were decreased in the aged muscle; FSO treatment increased these expression levels. Conversely, protein degradation markers such as atrogin-1 and MuRF-1 were increased in aged muscle, and FSO treatment decreased expression levels. Muscle mass, which was evaluated by muscle fiber CSA, muscle weight/body weight, and thickest diameter of the muscle, was reduced in aged mice, which was enhanced by FSO treatment. Muscle function, as evaluated by grip strength, was decreased in aged mice and increased following FSO treatment. FSO administration attenuated muscle mass and function by modulating satellite cell accumulation and function.

A reduced ability of satellite cells to repair damaged muscle fibers is considered one of the primary mechanisms underlying sarcopenia (Jang et al., 2011). Decreased satellite cell function and accumulation can be correlated with reduced regenerative potential (Collins et al., 2007). Our results revealed that FSO could attenuate aging-induced sarcopenia by increasing satellite cell accumulation and the myogenic ability of satellite cells.

In conclusion, the fermentation process increases muscle-enhancing biochemical substrates including GABA, lactate, BCAAs and FAAs. Furthermore, FSO enhanced autophagy in Tregs, increasing Treg accumulation and function in aged muscles. FSO increased Treg function, which, in turn, enhanced anti-inflammatory cytokines (IL-10 and TGF-β) and reduced pro-inflammatory cytokines (IL-17 and IFN-γ). In addition, FSO could lead to increased IL-33 and M2 polarization, which eventually elevates Areg, subsequently increasing satellite cell accumulation, as well as their myogenic function. Thus, FSO attenuated the age-associated decrease in muscle mass and function.

Supplementary Materials

Supplementary Materials

fas-26-6-406-suppl1.pdf

Competing interests

Kyoung-Min Rheu and Bae-Jin Lee are employed by Marine Bioprocess Co., Ltd.

Funding sources

This research was funded by the Ministry of Oceans and Fisheries of Korea (grant number 20190014).

Acknowledgements

Not applicable.

Availability of data and materials

Upon reasonable request, the datasets of this study can be available from the corresponding author.

Ethics approval and consent to participate

This study was conducted in accordance with the guide-lines of the Institutional Animal Care and Use Committee and was approved by the Institutional Review Board (or Ethics Committee) of Gachon University (approval no. LCDI-2021-0074).

References

1.

Afzali AM, Müntefering T, Wiendl H, Meuth SG, Ruck T. Skeletal muscle cells actively shape (auto)immune responses. Autoimmun Rev. 2018; 17:518-29

2.

Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med. 2007; 204:1057-69

3.

Arpaia N, Green JA, Moltedo B, Arvey A, Hemmers S, Yuan S, et al. A distinct function of regulatory T cells in tissue protection. Cell. 2015; 162:1078-89

4.

Bajić SS, Đokić J, Dinić M, Tomić S, Popović N, Brdarić E, et al. GABA potentiate the immunoregulatory effects of Lactobacillus brevis BGZLS10-17 via ATG5-dependent autophagy in vitro. Sci Rep. 2020; 10:1347

5.

Bang JS, Choung SY. Inhibitory effect of oyster hydrolysate on wrinkle formation against UVB irradiation in human dermal fibroblast via MAPK/AP-1 and TGFβ/Smad pathway. J Photochem Photobiol B. 2020; 209:111946

6.

Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsien RW, et al. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA. 2010; 107:2580-5

7.

Bodine SC, Latres E, Baumhueter S, Lai VKM, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001; 294:1704-8

8.

Brack AS, Rando TA. Tissue-specific stem cells: lessons from the skeletal muscle satellite cell. Cell Stem Cell. 2012; 10:504-14

9.

Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, et al. A special population of regulatory T cells potentiates muscle repair. Cell. 2013; 155:1282-95

10.

Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3+ T cells recruited to sites of sterile skeletal muscle injury regulate the fate of satellite cells and guide effective tissue regeneration. PLOS ONE. 2015; 10e0133101

11.

Collins CA, Zammit PS, Ruiz AP, Morgan JE, Partridge TA. A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells. 2007; 25:885-94

12.

Cui Y, Miao K, Niyaphorn S, Qu X. Production of gamma-aminobutyric acid from lactic acid bacteria: a systematic review. Int J Mol Sci. 2020; 21:995

13.

Deng B, Wehling-Henricks M, Armando Villalta S, Wang Y, Tidball JG. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol. 2012; 189:3669-80

14.

Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. Grip strength across the life course: normative data from twelve British studies. PLOS ONE. 2014; 9e113637

15.

Domingues-Faria C, Vasson MP, Goncalves-Mendes N, Boirie Y, Walrand S. Skeletal muscle regeneration and impact of aging and nutrition. Ageing Res Rev. 2016; 26:22-36

16.

Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018; 19:665-73

17.

Dumont NA, Wang YX, Rudnicki MA. Intrinsic and extrinsic mechanisms regulating satellite cell function. Development. 2015; 142:1572-81

18.

Ethgen O, Beaudart C, Buckinx F, Bruyère O, Reginster JY. The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int. 2017; 100:229-34

19.

Furukawa S, Moriyama M, Miyake K, Nakashima H, Tanaka A, Maehara T, et al. Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease. Sci Rep. 2017; 7:42413

20.

Harada Y, Harada Y, Elly C, Ying G, Paik JH, DePinho RA, et al. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med. 2010; 207:1381-91

21.

Jang YC, Sinha M, Cerletti M, Dall’Osso C, Wagers AJ. Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function. Cold Spring Harb Symp Quant Biol. 2011; 76:101-11

22.

Jeong A, Park BC, Kim HY, Choi JY, Cheon J, Park JH, et al. Efficacy and safety of fermented oyster extract for height of children with short stature: a randomized placebo-controlled trial. Integr Med Res. 2021; 10:100691

23.

Jin RM, Warunek J, Wohlfert EA. Therapeutic administration of IL-10 and amphiregulin alleviates chronic skeletal muscle inflammation and damage induced by infection. Immunohorizons. 2018; 2:142-54

24.

Ko CH, Wu SJ, Wang ST, Chang YF, Chang CS, Kuan TS, et al. Effects of enriched branched-chain amino acid supplementation on sarcopenia. Aging. 2020; 12:15091-103

25.

Kuswanto W, Burzyn D, Panduro M, Wang KK, Jang YC, Wagers AJ, et al. Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells. Immunity. 2016; 44:355-67

26.

Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T. The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm. 2017; 2017:3908061

27.

Mann G, Mora S, Madu G, Adegoke OAJ. Branched-chain amino acids: catabolism in skeletal muscle and implications for muscle and whole-body metabolism. Front Physiol. 2021; 12:702826

28.

Mazzoli R, Pessione E. The neuro-endocrinological role of microbial glutamate and GABA signaling. Front Microbiol. 2016; 7:1934

29.

Molagoda IMN, Athapaththu AMGK, Park EK, Choi YH, Jeon YJ, Kim GY. Fermented oyster (Crassostrea gigas) extract cures and prevents prednisolone-induced bone resorption by activating osteoblast differentiation. Foods. 2022; 11:678

30.

Oh S, Choi CH, Lee BJ, Park JH, Son KH, Byun K. Fermented oyster extract attenuated dexamethasone-induced muscle atrophy by decreasing oxidative stress. Molecules. 2021; 26:7128

31.

Ouyang W, Beckett O, Ma Q, Paik J, DePinho RA, Li MO. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol. 2010; 11:618-27

32.

Reid SNS, Park JH, Kim Y, Kwak YS, Jeon BH. In vitro and in vivo effects of fermented oyster-derived lactate on exercise endurance indicators in mice. Int J Environ Res Public Health. 2020; 17:8811

33.

Rudensky AY. Regulatory T cells and Foxp3. Immunol Rev. 2011; 241:260-8

34.

Saini J, McPhee JS, Al-Dabbagh S, Stewart CE, Al-Shanti N. Regenerative function of immune system: Modulation of muscle stem cells. Ageing Res Rev. 2016; 27:67-76

35.

Sambasivan R, Yao R, Kissenpfennig A, Van Wittenberghe L, Paldi A, Gayraud-Morel B, et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development. 2011; 138:3647-56

36.

ter Borg S, Luiking YC, van Helvoort A, Boirie Y, Schols JMGA, de Groot CPGM. Low levels of branched chain amino acids, eicosapentaenoic acid and micronutrients are associated with low muscle mass, strength and function in community-dwelling older adults. J Nutr Health Aging. 2019; 23:27-34

37.

Tidball JG, Wehling-Henricks M. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J Physiol. 2007; 578:327-36

38.

Wei J, Long L, Yang K, Guy C, Shrestha S, Chen Z, et al. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat Immunol. 2016; 17:277-85

39.

Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010; 22:124-31

40.

Zammit PS. Function of the myogenic regulatory factors Myf5, MyoD, myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis. Semin Cell Dev Biol. 2017; 72:19-32